Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-26-038692

Director returned 8,967,383 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Roivant Sciences Ltd. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-01 Returned to the company : show line 1 in the form −8,967,383 $5.00 $44,836,915 29,880,079 D
Loading xslF345X06/form4.xml…